Prefilled syringe needles versus standard removable needles for intravitreous injection

Retina

Volumn 26, Issue 6, 2006, Pages 679-683

  Kozak, Igor ^a   Dean, April ^b   Clark, Thomas M ^a   Falkenstein, Iryna ^a   Freeman, William R ^a,c  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b Precision Micro Devices   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Intravitreous injection; Needle design; Pegaptanib sodium; Triamcinolone acetonide

Indexed keywords

TRIAMCINOLONE ACETONIDE; APTAMER; PEGAPTANIB;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; MICROPHOTOGRAPHY; NEEDLE; NONHUMAN; OBSERVATIONAL STUDY; PHYSICIAN; VIDEORECORDING; ANIMAL; DRUG EFFECT; EQUIPMENT DESIGN; INJECTION; INSTRUMENTATION; PATHOPHYSIOLOGY; PRESSURE; PUNCTURE; SCLERA; SWINE; SYRINGE; VITREOUS BODY;

ANIMALS; APTAMERS, NUCLEOTIDE; EQUIPMENT DESIGN; HUMANS; INJECTIONS; NEEDLES; PRESSURE; PUNCTURES; SCLERA; SWINE; SYRINGES; VIDEO RECORDING; VITREOUS BODY;

EID: 33747336824     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006982-200607000-00015     Document Type: Article

References (12)

1. Gillies MC, Simpson JM, Luo W, et al. A randomized clinical trial of a single dose of intravitreal triamcinolone acetonide for neovascular age-related macular degeneration one-year results. Arch Ophthalmol 2003;121:667-673.
2. Martidis A, Duker JS, Greenberg PB, et al. Intravitreal triamcinolone for refractory diabetic macular oedema. Ophthalmology 2002;109:920-927.
3. Gillies MC, Simpson JM, Billson FA, et al. Safety of an intravitreal injection of triamcinolone results from a randomized clinical trial. Arch Ophthalmol 2004;122:336-340.
4. Soheilian M, Rafati N, Peyman GA. Prophylaxis of acute posttraumatic bacterial endophthalmitis with or without combined intraocular antibiotics: a prospective, double-masked randomized pilot study. Int Ophthalmol 2001;24:323-330.
5. Smiddy WE. Treatment outcomes of endogenous fungal endophthalmitis. Curr Opin Ophthalmol 1998;9:66-70.
6. Taskintuna I, Rahhal FM, Arevalo JF, et al. Low-dose intravitreal cidofovir (HPMPC) therapy of cytomegalovirus retinitis in patients with acquired immune deficiency syndrome. Ophthalmology 1997;104:1049-1057.
7. Jonas JB, Degenring RF, Krissig I, et al. Exudative age-related macular degeneration treated by intravitreal triamcinolone acetonide. A prospective comparative nonrandomized study. Eye 2005;19:163-170.
8. Krzystolik MG, Afshari MA, Adamis AP, et al. Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment. Arch Ophthalmol 2002;120:338-346.
9. Vinores SA. Technology evaluation: pegaptanib, Eyetech/ Pfizer. Curr Opin Mol Ther 2003;5:673-679.
10. Available at: www.pfizer.com/pfizer/download/uspi_macugen.pdf.
11. Aiello LP, Brucker AJ, Chang S, et al. Evolving guidelines for intravitreous injections. Retina 2004;24:S3-S19.
12. Kozak I, Cheng L, Freeman WR. Lidocaine gel anesthesia for intravitreal drug administration. Retina 2005;25:994 -998.